1,578
Views
13
CrossRef citations to date
0
Altmetric
Review

Improving vaccine efficacy against malignant glioma

, , , , , , , , , , , & , Ph.D show all
Article: e1196311 | Received 27 Apr 2016, Accepted 27 May 2016, Published online: 05 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Alice Giotta Lucifero & Sabino Luzzi. (2022) Emerging immune-based technologies for high-grade gliomas. Expert Review of Anticancer Therapy 22:9, pages 957-980.
Read now
Cunyi Zou, Chen Zhu, Gefei Guan, Qing Guo, Tianqi Liu, Shuai Shen, Zihao Yan, Xiaoyan Xu, Zhiguo Lin, Ling Chen, Anhua Wu & Wen Cheng. (2019) CD48 is a key molecule of immunomodulation affecting prognosis in glioma. OncoTargets and Therapy 12, pages 4181-4193.
Read now
Stefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, Jonathan G. Pol, Laurence Zitvogel, Guido Kroemer, Andrea Facciabene & Lorenzo Galluzzi. (2017) Trial watch: DNA-based vaccines for oncological indications. OncoImmunology 6:12.
Read now

Articles from other publishers (10)

Luis F. B. Marqueze, Amanda K. Costa, Giulia S. Pedroso, Franciane F. Vasconcellos, Bruna I. Pilger, Schellen Kindermann, Vanessa M. Andrade, Ana C. B. Alves, Tatyana Nery, Aderbal A. SilvaJr.Jr., Stephanie R. S. Carvalhal, Matheus F. Zazula, Katya Naliwaiko, Luiz C. Fernandes, Zsolt Radak & Ricardo A. Pinho. (2023) Regulation of Redox Profile and Genomic Instability by Physical Exercise Contributes to Neuroprotection in Mice with Experimental Glioblastoma. Antioxidants 12:7, pages 1343.
Crossref
Xuehua Zhang, Leilei Zhao, He Zhang, Yurui Zhang, Huanyu Ju, Xiaoyu Wang, Huan Ren, Xiao Zhu & Yucui Dong. (2022) The immunosuppressive microenvironment and immunotherapy in human glioblastoma. Frontiers in Immunology 13.
Crossref
Alice Giotta Lucifero & Sabino Luzzi. (2022) Immune Landscape in PTEN-Related Glioma Microenvironment: A Bioinformatic Analysis. Brain Sciences 12:4, pages 501.
Crossref
Sumbal Rasheed, Kanwal Rehman & Muhammad Sajid Hamid Akash. (2021) An insight into the risk factors of brain tumors and their therapeutic interventions. Biomedicine & Pharmacotherapy 143, pages 112119.
Crossref
Alice Giotta Lucifero & Sabino Luzzi. (2021) Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I). Brain Sciences 11:3, pages 386.
Crossref
Rimas V. Lukas, Derek A. Wainwright, Craig M. Horbinski, Fabio M. Iwamoto & Adam M. Sonabend. (2019) Immunotherapy Against Gliomas: is the Breakthrough Near?. Drugs 79:17, pages 1839-1848.
Crossref
Milad Abolhalaj, David Askmyr, Christina Alexandra Sakellariou, Kristina Lundberg, Lennart Greiff & Malin Lindstedt. (2018) Profiling dendritic cell subsets in head and neck squamous cell tonsillar cancer and benign tonsils. Scientific Reports 8:1.
Crossref
Houliang Deng, Jianming Zeng, Ting Zhang, Longcai Gong, Hongjie Zhang, Edwin Cheung, Chris Jones & Gang Li. (2018) Histone H3.3K27M Mobilizes Multiple Cancer/Testis (CT) Antigens in Pediatric Glioma. Molecular Cancer Research 16:4, pages 623-633.
Crossref
Ana Miranda, María Blanco-Prieto, João Sousa, Alberto Pais & Carla Vitorino. (2017) Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches. International Journal of Pharmaceutics 531:1, pages 372-388.
Crossref
Lijie Zhai, Erik Ladomersky, Carlos R. Dostal, Kristen L. Lauing, Kathleen Swoap, Leah K. Billingham, Galina Gritsina, Meijing Wu, Robert H. McCusker, David C. Binder & Derek A. Wainwright. (2017) Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma. Brain, Behavior, and Immunity 62, pages 24-29.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.